NPI: 1952740672 · GRANTS PASS, OR 97527 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/15/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/15/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 454 | $56K |
| 2020 | 10,585 | $579K |
| 2021 | 17,827 | $684K |
| 2022 | 15,230 | $638K |
| 2023 | 5,083 | $394K |
| 2024 | 2,669 | $370K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,668 | 1,527 | $2.72M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,950 | 908 | $4K |
| 90674 | 47 | 37 | $769.38 | |
| G0008 | Administration of influenza virus vaccine | 70 | 51 | $532.47 |
| J1756 | Injection, iron sucrose, 1 mg | 4,141 | 1,045 | $505.56 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 556 | 359 | $483.62 |
| A4657 | Syringe, with or without needle, each | 4,987 | 1,400 | $146.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,066 | 471 | $5.72 |
| 85041 | 352 | 173 | $0.00 | |
| 83540 | 326 | 161 | $0.00 | |
| 85048 | 326 | 161 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,020 | 309 | $0.00 |
| 83970 | 252 | 110 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 177 | 55 | $0.00 |
| 82728 | 325 | 161 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 259 | 90 | $0.00 |
| 83550 | 326 | 161 | $0.00 |